Within a cellular clinical viewpoint, Relafen 750 (Naproxen) exhibits unique behaviors. It functions primarily as a NSAID medication , selectively suppressing cyclooxygenase-2 (COX-2), an catalyst implicated in prostaglandin synthesis . This focused inhibition generates decreased inflammation and ache, offering potential effects for patients experi